Sun Pharma was established with five psychiatry products and a two person marketing team. A compact manufacturing facility for tablets and capsules was set up at Vapi, Gujarat.
Sun Pharma established its first research center, creating the base for strong product and process development enabling growth in the subsequent years
An API plant at Ahmednagar was acquired from Knoll Pharma. Company sales spread to 24 countries.
Sun purchased equity stakes in TDPL and MJ Pharma, as well as in the company's our first international acquisition, Detroit based Caraco Pharmaceutical Laboratories. A new research facility in Mumbai was set up.
A basket of products were acquired from Natco Pharma. A new formulation plant in Silvassa commenced operations.
This year Sun Pharma was ranked among the top 10 pharmaceutical companies in India. Milmet Labs and Gujarat Lyka Organics were acquired.
Sun Pharma became the fifth largest Indian pharmaceutical company this year. Pradeep Drug Company was acquired.
A new formulation plant was built in Jammu. The first joint venture manufacturing unit, in Dhaka, Bangladesh was commissioned. Phlox Pharma and niche brands from Women's First Healthcare were acquired.
Sun Pharma bought a plant in Bryan, Ohio, US and the business of ICN, Hungary from Valeant Pharma. Intellectual property and assets of Able Labs were bought from the US District Bankruptcy court in New Jersey.
It was decided to demerge the research company into a separate entity Sun Pharma Advanced Research Company. This company is listed on the stock exchanges in India, the first pure research company to do so.
Sun Pharma acquired controlling stake in Israel based Taro Pharmaceuticals, effectively doubling the company's US business.
* All logos and trademarks are the property of the relevant trademark owners